Advertisement

Topics

Anacor Strikes Acne Deal With Medicis

10:29 EST 10 Feb 2011 |

Palo Alto, CA-based Anacor Pharmaceuticals (NASDAQ: ANAC) said today it has formed a research collaboration with Scottsdale, AZ-based Medicis Pharmaceutical (NYSE: MRX) to discover and develop boron-based small molecule drugs against acne. Anacor will get $7 million upfront, and could get milestone payments of as much as $153 million. Anacor went public back in November, [...]

Original Article: Anacor Strikes Acne Deal With Medicis

NEXT ARTICLE

More From BioPortfolio on "Anacor Strikes Acne Deal With Medicis"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...

Acne
Acne is a common skin condition that causes spots to develop on the skin, usually on the face, back and chest..  The spots can range from blackheads and whiteheads which are often mild, to inflamed pus-filled pustules and cysts, which can be severe ...